|
2024
|
Invention
|
Fc domain variants with enhanced fc receptor binding. The present disclosure provides Fc domain v... |
|
|
Invention
|
Mmp13 binding immunoglobulins.
The present invention relates to immunoglobulins that specificall... |
|
|
Invention
|
Bi- and multivalent albumin binders.
The present technology relates to bi- and multivalent album... |
|
|
Invention
|
Bi- and multivalent albumin binders. The present technology relates to bi- and multivalent albumi... |
|
|
Invention
|
Method for the production of domain antibodies.
The present invention relates to a method for pr... |
|
|
Invention
|
Improved fcrn antagonists for treatment of igg-related diseases and disorders. The present invent... |
|
|
Invention
|
Immunoglobulin single variable domains targeting pd-l1. The present technology provides polypepti... |
|
|
Invention
|
Chimeric proteins for modulating cytokine receptor activity. The present invention belongs to the... |
|
|
Invention
|
Polypeptides binding to the neonatal fc receptor.
The present technology relates to polypeptides... |
|
|
Invention
|
Polypeptides binding to the neonatal fc receptor. The present technology relates to polypeptides ... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell re... |
|
|
Invention
|
Serum albumin binders.
The present invention relates to amino acid sequences that can bind to se... |
|
2023
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf alpha.
The... |
|
|
Invention
|
Protein-based conjugation carriers.
The present technology relates to the field of drug delivery... |
|
|
Invention
|
Protein-based conjugation carriers. DD value greater than 5x10-4 mol/litre. |
|
|
Invention
|
Amino acid sequences that modulate the interaction between cells of the immune system.
The prese... |
|
|
Invention
|
Glycoengineered fc variant polypeptides with enhanced effector function.
The present disclosure ... |
|
|
Invention
|
Glycoengineered fc variant polypeptides with enhanced effector function. The present disclosure p... |
|
|
Invention
|
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta.
Polypeptides are pro... |
|
|
Invention
|
Polypeptides binding adamts5, mmp13 and aggrecan.
The present invention relates to polypeptides ... |
|
|
Invention
|
Polypeptides binding to a specific epitope of the neonatal fc receptor.
The present invention re... |
|
|
Invention
|
Polypeptides binding to a specific epitope of the neonatal fc receptor |
|
|
Invention
|
Polypeptides binding to a specific epitope of the neonatal fc receptor. in vivoin vivo of therape... |
|
|
Invention
|
Cx3cr1-binding compounds, uses thereof and related methods. The present technology relates to a p... |
|
|
Invention
|
Immunoglobulin single variable domains targeting t cell receptor |
|
|
Invention
|
Immunoglobulin single variable domains targeting t cell receptor. The present technology provides... |
|
2022
|
Invention
|
Aggrecan binding immunoglobulins.
The present invention relates to immunoglobulins that specific... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting tcr.alpha..beta., cd33 a... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting tcrαβ, cd33 and cd123. T... |
|
|
Invention
|
Obtaining sequence information for target multivalent immunoglobulin single variable domains. A c... |
|
|
Invention
|
Cysteine linked nanobody dimers.
The present invention relates to dimers comprising a first poly... |
|
|
Invention
|
Nucleic acids encoding cx3cr1-binding polypeptides comprising immunoglobulin single variable doma... |
|
|
Invention
|
Nanobodies against tumor necrosis factor-alpha.
The present invention relates to improved Nanobo... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting tnfa and il-23.
The pre... |
|
|
Invention
|
Glycosylated immunoglobulin single variable domains.
The present invention relates to glycosylat... |
|
|
Invention
|
Adamts binding immunoglobulins. The present invention relates to immunoglobulins that bind ADAMTS... |
|
2021
|
Invention
|
T cell recruiting polypeptides based on tcr alpha/beta reactivity. The present technology provide... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-α. The pres... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha. The ... |
|
|
Invention
|
Bispecific nanobodies.
The present disclosure relates to bispecific polypeptides comprising a fi... |
|
|
Invention
|
Formulations of single domain antigen binding molecules.
The invention relates to formulations o... |
|
|
Invention
|
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslp.
The pre... |
|
|
Invention
|
Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single ... |
|
|
Invention
|
Polypeptides antagonizing wnt signaling in tumor cells. The invention provides LRP5-binding polyp... |
|
|
Invention
|
Method for the production and purification of multivalent immunoglobulin single variable domains.... |
|
2016
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of auto immune disorders, disorders ... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of pain, viral diseases, namely herp... |
|
2005
|
G/S
|
Pharmaceutical and veterinary products for the treatment of viral diseases, namely, acquired immu... |
|
|
G/S
|
Pharmaceutical products for the treatment of viral diseases, namely, acquired immune deficiency s... |
